162 related articles for article (PubMed ID: 2004454)
1. Performance of techniques used to detect drugs of abuse in urine: study based on external quality assessment.
Wilson JF; Williams J; Walker G; Toseland PA; Smith BL; Richens A; Burnett D
Clin Chem; 1991 Mar; 37(3):442-7. PubMed ID: 2004454
[TBL] [Abstract][Full Text] [Related]
2. External quality assessment of techniques for the detection of drugs of abuse in urine.
Wilson JF; Smith BL; Toseland PA; Williams J; Burnett D; Hirst AD; Watson ID; Horn AN
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():335-42. PubMed ID: 7979098
[TBL] [Abstract][Full Text] [Related]
3. Detection of drugs of abuse in exhaled breath from users following recovery from intoxication.
Beck O; Stephanson N; Sandqvist S; Franck J
J Anal Toxicol; 2012; 36(9):638-46. PubMed ID: 23045289
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
Wilson JF; Smith BL
Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
[TBL] [Abstract][Full Text] [Related]
6. Thin-layer chromatographic detection of barbiturates, narcotics, and amphetamines in urine of patients receiving psychotropic drugs.
Heaton AM; Blumberg AG
J Chromatogr; 1969 May; 41(3):367-70. PubMed ID: 5796330
[No Abstract] [Full Text] [Related]
7. Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse.
Mulé SJ; Bastos ML; Jukofsky D
Clin Chem; 1974 Feb; 20(2):243-8. PubMed ID: 4130418
[No Abstract] [Full Text] [Related]
8. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
[TBL] [Abstract][Full Text] [Related]
9. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
Abou El Hassan M; Colantonio D; Likhodii S; Nassar BA
Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
[TBL] [Abstract][Full Text] [Related]
10. Detection of drugs in urine for methadone treatment programs.
Baselt RC; Casarett LJ
J Chromatogr; 1971 Apr; 57(1):139-41. PubMed ID: 5103555
[No Abstract] [Full Text] [Related]
11. Experience in the identification of abuse drugs in urines collected under Treatment Alternatives to Street Crime.
Cordova VF; Banford TA
J Forensic Sci; 1975 Jan; 20(1):58-70. PubMed ID: 1117273
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.
Mulé SJ; Jukofsky D; Kogan M; De Pace A; Verebey K
Clin Chem; 1977 May; 23(5):796-801. PubMed ID: 322891
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening.
Mulé SJ; Casella GA
J Anal Toxicol; 1988; 12(2):102-7. PubMed ID: 3379919
[TBL] [Abstract][Full Text] [Related]
14. Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion.
Concheiro M; De Castro A; Quintela O; Cruz A; López-Rivadulla M
J Anal Toxicol; 2007; 31(9):573-80. PubMed ID: 18093416
[TBL] [Abstract][Full Text] [Related]
15. A hybrid liquid chromatography-mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer.
Dowling G; Regan L; Tierney J; Nangle M
J Chromatogr A; 2010 Oct; 1217(44):6857-66. PubMed ID: 20855077
[TBL] [Abstract][Full Text] [Related]
16. Assessment of an automated immunoassay based on kinetic interaction of microparticles in solution for determination of opiates and cocaine metabolite in urine.
Smith FP; Lora-Tamayo C; Carvajal R; Caddy B; Tagliaro F
Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():81-4. PubMed ID: 9022892
[TBL] [Abstract][Full Text] [Related]
17. Utilization of thin-layer chromatography and enzyme immunoassay systems to screen and confirm the presence of morphine, codeine, phencyclidine and benzoylecgonine.
Michalek RW; Rejent TA
J Anal Toxicol; 1980; 4(4):215-6. PubMed ID: 6109793
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase extraction and HPLC-UV confirmation of drugs of abuse in urine.
Ferrara SD; Tedeschi L; Frison G; Castagna F
J Anal Toxicol; 1992; 16(4):217-22. PubMed ID: 1323732
[TBL] [Abstract][Full Text] [Related]
19. Rapid screening and confirmation of amphetamine, methamphetamine, methadone, and methadone metabolite in urine by gas/thin layer chromatography.
Jain NC; Budd RD; Leung WJ; Sneath TC
J Chromatogr Sci; 1976 Jun; 14(6):293-5. PubMed ID: 1270567
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Keystone Diagnostics Quik Test using previously screened urine specimens.
Bogema S; Schwartz R; Godwin I
J Anal Toxicol; 1988; 12(5):272-3. PubMed ID: 3226124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]